VITEK MS CLINICAL REAGENT VITEK MS-DS, CATALOG 410893
Published January 11, 2023 · Recall initiated: November 9, 2022
Summary
FDA records medical device Class II recall Z-0814-2023, published January 11, 2023 and initiated November 9, 2022. Recalling firm: Biomerieux Inc; Status: Ongoing; Reported quantity: 13 units; Lot: UDI/DI 03573026359096, Batch Numbers: 11111288BM. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
As the temperature and time out of range was exceeded, product performances cannot be guaranteed
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Biomerieux Inc
- Distributor
- US Nationwide distribution.
- Lot
- UDI/DI 03573026359096, Batch Numbers: 11111288BM
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811September 30, 2026
- FDAVITEK 2 AST-N447 TEST KIT Product reference 424620July 15, 2026
- FDAVITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n) o Ceftazidime/avibactam (cza02n) oFebruary 11, 2026
- FDAVITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REFMay 1, 2024
- FDAPPM CLINICAL CRAPONNE CHROMID VRE 20 PLT US, CATALOG 43851January 11, 2023
- FDAETEST CLINICAL ETEST MEROPENEM/VABORBACTAM MEV US S30, CATALOG 421560January 11, 2023
Questions about this recall
Was VITEK MS CLINICAL REAGENT VITEK MS-DS, CATALOG 410893 recalled?
Yes. FDA published recall Z-0814-2023 on January 11, 2023. Reported hazard: As the temperature and time out of range was exceeded, product performances cannot be guaranteed
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail